Ge Xiaolong, Cao Yu, Wang Hongkan, Ding Chao, Tian Hongliang, Zhang Xueying, Gong Jianfeng, Zhu Weiming, Li Ning
Department of General Surgery, Jinling Hospital, Medical School of Nanjing University, 305 East Zhongshan Road, Nanjing, 210002, China.
Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China.
World J Surg Oncol. 2017 Jan 10;15(1):15. doi: 10.1186/s12957-016-1092-1.
The ratio of C-reactive protein to albumin, as a novel inflammation-based prognostic score, is associated with outcomes in cancer and septic patients. The diagnostic accuracy of the CRP/albumin ratio has not been assessed in colorectal surgery for postoperative complications.
A total of 359 patients undergoing major colorectal surgery between 2012 and 2015 were eligible for this study. Uni- and multivariate analyses were performed to identify risk factors for postoperative complications. Receiver operating characteristic curves were developed to examine the cutoff values and diagnostic accuracy of the CRP/albumin ratio and postoperative CRP levels.
Among all the patients, 139 (38.7%) were reported to have postoperative complications. The CRP/albumin ratio was an independent risk factor for complications (OR 4.413; 95% CI 2.463-7.906; P < 0.001), and the cutoff value was 2.2, which had a higher area under the curve compared to CRP on postoperative day 3 (AUC 0.779 vs 0.756). The CRP/albumin ratio also had a higher positive predictive value than CRP levels on postoperative day 3. Patients with CRP/albumin ≥2.2 suffered more postoperative complications (60.8% vs 18.6%, P < 0.001), longer postoperative stays (10 (4-71) vs 7 (3-78) days, P < 0.001), and increased surgical site infections (SSIs) (21.1% vs 4.8%, P < 0.001) than those with CRP/albumin <2.2.
The ratio of C-reactive protein to albumin could help to identify patients who have a high probability of postoperative complications, and the ratio has higher diagnostic accuracy than C-reactive protein alone for postoperative complications in colorectal surgery.
C反应蛋白与白蛋白的比值作为一种基于炎症的新型预后评分,与癌症患者和脓毒症患者的预后相关。尚未评估C反应蛋白/白蛋白比值在结直肠手术中对术后并发症的诊断准确性。
2012年至2015年间,共有359例行大型结直肠手术的患者符合本研究条件。进行单因素和多因素分析以确定术后并发症的危险因素。绘制受试者工作特征曲线,以检验C反应蛋白/白蛋白比值和术后C反应蛋白水平的临界值及诊断准确性。
在所有患者中,139例(38.7%)报告有术后并发症。C反应蛋白/白蛋白比值是并发症的独立危险因素(比值比4.413;95%可信区间2.463 - 7.906;P < 0.001),临界值为2.2,与术后第3天的C反应蛋白相比,其曲线下面积更高(曲线下面积0.779对0.756)。C反应蛋白/白蛋白比值的阳性预测值也高于术后第3天的C反应蛋白水平。C反应蛋白/白蛋白≥2.2的患者术后并发症更多(60.8%对18.6%,P < 0.001),术后住院时间更长(10(4 - 7)天对7(3 - 78)天,P < 0.001),手术部位感染发生率更高(21.1%对4.8%,P < 0.001),而C反应蛋白/白蛋白<2.2的患者则不然。
C反应蛋白与白蛋白的比值有助于识别术后并发症发生概率高的患者,且该比值在结直肠手术中对术后并发症的诊断准确性高于单独的C反应蛋白。